Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Molecular Imaging-Derived Biomarker of PSMA Expression - Revealing Theranostic Potential in Gastroenterologic Tumors

NCT05547919 is registered in ClinicalTrials.gov with Wuerzburg University Hospital as lead sponsor.

NCT NCT05547919
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05547919 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Molecular Imaging-Derived Biomarker of PSMA Expression - Revealing Theranostic Potential in Gastroenterologic Tumors
Lead sponsor
Wuerzburg University Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
October 1, 2022
Completion date
October 1, 2026
Enrollment
46 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gastrointestinal cancer